Morgan Stanley 13D and 13G filings for Integra LifeSciences Holdings Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 12:05 pm Sale |
2023-12-31 | 13G | Integra LifeSciences Holdings Corporation IART |
MORGAN STANLEY MS |
4,634,346 5.900% |
-1,047,137 (-18.43%) |
Filing |
| 2023-02-09 2:52 pm Purchase |
2022-12-30 | 13G | Integra LifeSciences Holdings Corporation IART |
MORGAN STANLEY MS |
5,681,483 6.800% |
320,012 (+5.97%) |
Filing |
| 2022-02-11 11:58 am Purchase |
2021-12-31 | 13G | Integra LifeSciences Holdings Corporation IART |
MORGAN STANLEY MS |
5,361,471 6.300% |
5,361,471 (New Position) |
Filing |